80
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Imaging Features and Prognostic Value of FDG PET/CT in Patients with Intravascular Large B-Cell Lymphoma

, , , & ORCID Icon
Pages 7289-7297 | Published online: 21 Sep 2021

References

  • SabattiniE, BacciF, SagramosoC, PileriSA. WHO classification of tumours of haematopoietic and lymphoid tissues in 2008: an overview. Pathologica. 2010;102(3):83–87.21171509
  • ShimadaK, KinoshitaT, NaoeT, NakamuraS. Presentation and management of intravascular large B-cell lymphoma. Lancet Oncol. 2009;10(9):895–902. doi:10.1016/s1470-2045(09)70140-819717091
  • PonzoniM, FerreriAJ, CampoE, et al. Definition, diagnosis, and management of intravascular large B-cell lymphoma: proposals and perspectives from an international consensus meeting. J Clin Oncol. 2007;25(21):3168–3173. doi:10.1200/JCO.2006.08.231317577023
  • ShimadaK, MatsueK, YamamotoK, et al. Retrospective analysis of intravascular large B-cell lymphoma treated with rituximab-containing chemotherapy as reported by the IVL study group in Japan. J Clin Oncol. 2008;26(19):3189–3195. doi:10.1200/jco.2007.15.427818506023
  • HongJY, KimHJ, KoYH, et al. Clinical features and treatment outcomes of intravascular large B-cell lymphoma: a single-center experience in Korea. Acta Haematol. 2014;131(1):18–27. doi:10.1159/00035106024021554
  • HaJM, KimE, LeeWJ, et al. Unusual manifestation of intravascular large B-cell lymphoma: severe hypercalcemia with parathyroid hormone-related protein. Cancer Res Treat. 2014;46(3):307–311. doi:10.4143/crt.2014.46.3.30725038766
  • HoshinoA, KawadaE, UkitaT, et al. Usefulness of FDG-PET to diagnose intravascular lymphomatosis presenting as fever of unknown origin. Am J Hematol. 2004;76(3):236–239. doi:10.1002/ajh.2009915224358
  • YamashitaH, SuzukiA, TakahashiY, KubotaK, KanoT, MimoriA. Intravascular large B-cell lymphoma with diffuse FDG uptake in the lung by 18FDG-PET/CT without chest CT findings. Ann Nucl Med. 2012;26(6):515–521. doi:10.1007/s12149-012-0600-922539250
  • YoonSE, KimWS, KimSJ. Asian variant of intravascular large B-cell lymphoma: a comparison of clinical features based on involvement of the central nervous system. Korean J Intern Med. 2020;35(4):946–956. doi:10.3904/kjim.2018.39631752477
  • ShusterJJ. Median follow-up in clinical trials. J Clin Oncol. 1991;9(1):191–192. doi:10.1200/JCO.1991.9.1.1911985169
  • BarringtonSF, MikhaeelNG. PET scans for staging and restaging in diffuse large B-cell and follicular lymphomas. Curr Hematol Malig Rep. 2016;11(3):185–195. doi:10.1007/s11899-016-0318-127095319
  • McDonoughSP, Van WinkleTJ, ValentineBA, vanGesselYA, SummersBA. Clinicopathological and immunophenotypical features of canine intravascular lymphoma (malignant angioendotheliomatosis). J Comp Pathol. 2002;126(4):277–288. doi:10.1053/jcpa.2002.055312056776
  • ThomasCA, GuileyardoJM, KrauseJR. An intravascular lymphoma with extravascular tendencies. Proc Bayl Univ Med Cent. 2014;27(4):341–343. doi:10.1080/08998280.2014.1192915325484506
  • NgeowJYY, QuekRHH, NgDCE, et al. High SUV uptake on FDG-PET/CT predicts for an aggressive B-cell lymphoma in a prospective study of primary FDG-PET/CT staging in lymphoma. Ann Oncol. 2009;20(9):1543–1547. doi:10.1093/annonc/mdp03019474116
  • SchoderH, NoyA, GonenM, et al. Intensity of 18 fluorodeoxyglucose uptake in positron emission tomography distinguishes between indolent and aggressive non-Hodgkin’s lymphoma. J Clin Oncol. 2005;23(21):4643–4651. doi:10.1200/jco.2005.12.07215837966
  • LongNM, SmithCS. Causes and imaging features of false positives and false negatives on F-PET/CT in oncologic imaging. Insights Imaging. 2011;2(6):679–698. doi:10.1007/s13244-010-0062-322347986
  • LiewCL, ShyuWC, TsaoWL, LiH. Intravascular lymphomatosis mimics a cerebral demyelinating disorder. Acta Neurol Taiwan. 2006;15(4):264–268.17214091
  • SpaepenK, StroobantsS, DupontP, et al. Prognostic value of positron emission tomography (PET) with fluorine-18 fluorodeoxyglucose ([18F]FDG) after first-line chemotherapy in non-Hodgkin’s lymphoma: is [18F]FDG-PET a valid alternative to conventional diagnostic methods?J Clin Oncol. 2001;19(2):414–419. doi:10.1200/jco.2001.19.2.41411208833
  • LiuB, EzeoguL, ZellmerL, YuB, XuN, Joshua LiaoD. Protecting the normal in order to better kill the cancer. Cancer Med. 2015;4(9):1394–1403. doi:10.1002/cam4.48826177855
  • CheokCF. Protecting normal cells from the cytotoxicity of chemotherapy. Cell Cycle. 2012;11(12):2227–2228. doi:10.4161/cc.2096122684296
  • YiHK, ParkYJ, BaeJH, et al. Inverse prognostic relationships of (18) F-FDGPET/CT metabolic parameters in patients with distal bile duct cancer undergoing curative surgery. Nucl Med Mol Imaging. 2018;52(5):334–341. doi:10.1007/s13139-018-0542-930344781